The U.S. clinical laboratory services market expands through regulatory-driven compliance investments, precision-genomics ...

Global Drug Screening Market is estimated at $4.8 Bn (2020) growing at a CAGR of 15.8% through 2020-2025. The market growth is driven by growing drug use after COVID-19 pandemic and increase in abuse ...

HepQuant, LLC, a leader in developing noninvasive, blood-based, quantitative testing to assess liver health, is proud to announce ISO 13485 certification as its latest milestone in operational ...

Receiving ganciclovir prophylaxis did not have a benefit on respiratory support-free days vs. placebo in adults with ...

Cepheid today announced that Health Canada has issued Cepheid a medical device licence for Xpert® HIV-1 Viral Load XC, a next-generation extended-coverage (XC) test intended to aid in assessing HIV ...

Background Current treatments with tyrosine kinase inhibitors and immune checkpoint inhibitors have limited efficacy for ...

As researchers work to improve treatment of Alzheimer’s disease, new research by UCLA Health identified a candidate drug that reduces levels of a toxic form of a protein in the brain caused by the ...

President Donald Trump will reintroduce a sweeping Medicare drug-pricing plan that failed to advance in his first term.

YUFLYMA® (adalimumab-aaty) is a high-concentration (100mg/mL) and citrate-free formulation of Humira® (adalimumab) biosimilar ...

Bloodstream infections caused by yeast rose by 4% in 2024, compared to 2023. Latest data from UK Health Security Agency ...

Treatment beyond initial investigator-assessed RECIST v1.1–defined progression was permitted if the patient had investigator-assessed clinical ... centralized laboratory (Agilent Technologies/Dako ...

Evidence is mounting that clinicians can treat serious genetic disorders prenatally by injecting medicine into the amniotic fluid, thus preventing damage that begins in utero.